Go Pro

Oncolytics Biotech (ONCY) Earnings Date, Estimates & Call Transcripts

Oncolytics Biotech logo
$0.83 -0.01 (-1.63%)
Closing price 08/19/2026 04:00 PM Eastern
Extended Trading
$0.84 +0.01 (+1.08%)
As of 07:21 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Oncolytics Biotech Earnings Summary

Oncolytics Biotech issued Q2 2026 earnings on August 12, 2026, reporting an EPS of -$0.08, which missed analysts' consensus estimates of -$0.05 by $0.03. With a trailing EPS of -$0.34, Oncolytics Biotech's earnings are expected to grow next year, from ($0.25) to ($0.19) per share.

Latest Q2
Earnings Date
Aug. 12Estimated
Consensus EPS
(Aug. 12)
-$0.05
Actual EPS
(Aug. 12)
-$0.08 Missed By -$0.03

Q2 2026 Earnings Resources

Get Oncolytics Biotech Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Oncolytics Biotech and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ONCY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Oncolytics Biotech Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$0.06-$0.03-$0.05
Q2 20262-$0.07-$0.06-$0.07
Q3 20262-$0.07-$0.06-$0.07
Q4 20262-$0.06-$0.06-$0.06
FY 2026 8 -$0.26 -$0.21 -$0.24
Q1 20271-$0.04-$0.04-$0.04
Q2 20271-$0.04-$0.04-$0.04
Q3 20271-$0.03-$0.03-$0.03
Q4 20271-$0.03-$0.03-$0.03

Oncolytics Biotech Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026-$0.0538-$0.08 -$0.0262-$0.08--
5/14/2026Q1 2026-$0.05-$0.08 -$0.03-$0.08--
3/31/2026Q4 2025-$0.06-$0.08 -$0.02-$0.08--
11/12/2025Q3 2025-$0.12-$0.10+$0.02-$0.10--
8/8/2025Q2 2025-$0.11-$0.05+$0.06-$0.05--
5/14/2025Q1 2025-$0.09-$0.06+$0.03-$0.06--

Oncolytics Biotech Earnings - Frequently Asked Questions

Oncolytics Biotech (NASDAQ:ONCY) last announced its quarterly earning data on Wednesday, August 12, 2026. Learn more on ONCY's earnings history.

In the previous quarter, Oncolytics Biotech (NASDAQ:ONCY) missed the analysts' consensus estimate of ($0.05) by $0.03 with a reported earnings per share (EPS) of ($0.08). Learn more on analysts' earnings estimate vs. ONCY's actual earnings.

Oncolytics Biotech's earnings report can be found in their filing with the SEC.
View SEC filing

Oncolytics Biotech (NASDAQ:ONCY) has a recorded net income of -$28.76 million. ONCY has generated -$0.34 earnings per share over the last four quarters.

Oncolytics Biotech's earnings are expected to grow from ($0.25) per share to ($0.19) per share in the next year.


Earnings data for NASDAQ:ONCY is sourced from Fiscal.ai, with the most recent quarter reported on 8/12/2026. New results are added as companies report their earnings.
From Our Partners